Talampanel

被引：61

作者：

Howes, John F.

Bell, Cynthia ^{[1
]}

机构：

[1] IVAX Res Inc, Dept New Drug Dev, Miami, FL 33137 USA

[2] IVAX Res Inc, Dept Oncol, Miami, FL 33137 USA

[3] IVAX Res Inc, Dept CNS, Miami, FL 33137 USA

来源：

NEUROTHERAPEUTICS | 2007年 / 4卷 / 01期

关键词：

AMPA; epilepsy; glutamate; neuroprotection; talampanel;

D O I：

10.1016/j.nurt.2006.11.001

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Talampanel is a novel anticonvulsant that acts as an allosteric inhibitor of the AMPA receptor. Talampanel has a broad spectrum of action in animal models of epilepsy and neuroprotection. Clinical experience to date has been able to show effectiveness in reduction of seizures in patients with refractory partial seizures.

引用

收藏

页码：126 / 129

页数：4

相关论文

共 24 条

[1] Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats [J].

Belayev, L ;

Alonso, OF ;

Liu, YT ;

Chappell, AS ;

Zhao, WH ;

Ginsberg, MD ;

Busto, R .

JOURNAL OF NEUROTRAUMA, 2001, 18 (10) :1031-1038

[2] The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam [J].

Borowicz, KK ;

Kleinrok, Z ;

Czuczwar, SJ .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 361 (06) :629-635

[3] THE NONCOMPETITIVE AMPA/KAINATE RECEPTOR ANTAGONIST, GYKI-52466, POTENTIATES THE ANTICONVULSANT ACTIVITY OF CONVENTIONAL ANTIEPILEPTICS [J].

BOROWICZ, KK ;

GASIOR, M ;

KLEINROK, Z ;

CZUCZWAR, SJ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (03) :319-326

[4]

Buchwald P, 2006, PHARMAZIE, V61, P125

[5] Unified pharmacogenetics-based parent-metabolite pharmacokinetic model incorporating acetylation polymorphism for talampanel in humans [J].

Buchwald, P ;

Juhász, A ;

Bell, C ;

Pátfalusi, M ;

Howes, J ;

Bodor, N .

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2005, 32 (3-4) :377-400

[6] A crossover, add-on trial of talampanel in patients with refractory partial seizures [J].

Chappell, AS ;

Sander, JW ;

Brodie, MJ ;

Chadwick, D ;

Lledo, A ;

Zhang, D ;

Bjerke, J ;

Kiesler, GM ;

Arroyo, S .

NEUROLOGY, 2002, 58 (11) :1680-1682

[7] LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs [J].

Czuczwar, SJ ;

Swiader, M ;

Kuzniar, H ;

Gasior, M ;

Kleinrok, Z .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 359 (2-3) :103-109

[8] The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia [J].

Erdö, F ;

Berzenyi, P ;

Andrási, F .

BRAIN RESEARCH BULLETIN, 2005, 66 (01) :43-49

[9] Talampanel improves the functional deficit after transient focal cerebral ischemia in rats.: A 30-day follow up study [J].

Erdo, F ;

Berzsenyi, P ;

Német, L ;

Andrási, F .

BRAIN RESEARCH BULLETIN, 2006, 68 (04) :269-276

[10] Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice [J].

Erdö, F ;

Trapp, T ;

Mies, G ;

Hossmann, KA .

ACTA NEUROPATHOLOGICA, 2004, 107 (02) :127-136